Presentation Title
The Utility of Gadolinium Contrast Agents in Older Multiple Sclerosis Patients not on Disease Modifying Therapy
Abstract
Multiple sclerosis (MS) is an autoimmune disease defined by the presence of multiple foci of white matter inflammation and demyelination in the central nervous system (CNS). Contrast-enhanced magnetic resonance imaging (MRI) is a crucial tool in assessing and monitoring disease activity in patients with this condition. This retrospective observational study aims to assess the outcomes and thus utility of contrast-enhanced imaging in older patients that have stopped Disease Modifying Therapy (DMT).
Primary Faculty Mentor Name
Adam Ulano, MD
Status
Medical Students
Student College
Larner College of Medicine
Program/Major
Health Sciences
Primary Research Category
Health Sciences
The Utility of Gadolinium Contrast Agents in Older Multiple Sclerosis Patients not on Disease Modifying Therapy
Multiple sclerosis (MS) is an autoimmune disease defined by the presence of multiple foci of white matter inflammation and demyelination in the central nervous system (CNS). Contrast-enhanced magnetic resonance imaging (MRI) is a crucial tool in assessing and monitoring disease activity in patients with this condition. This retrospective observational study aims to assess the outcomes and thus utility of contrast-enhanced imaging in older patients that have stopped Disease Modifying Therapy (DMT).